@article{c9e7fc5962584979b22fb87bd1d6b492,
title = "PDGFR inhibition using imatinib (I) combined with docetaxel (D), a potential new treatment strategy in the treatment of recurrent non-small cell lung cancer (NSCLC): Preliminary efficacy results",
author = "Huang, \{C. H.\} and Williamson, \{S. K.\} and VanVeldhuizen, \{P. J.\} and Hsueh, \{C. T.\} and A. Allen and H. Smith and M. Mayo and O. Tawfik and Uypeckcuat, \{A. M.\} and K. Kelly",
note = "19055 Background: Anti-angiogenesis is the new paradigm in the management of non-small cell lung cancer. Platelet Derived Growth Factor Receptor alpha (PDGFR-alpha) is involved in angiogenesis and its expression has been found in lung cancer. Preclinical models have shown that I inhibit PDGFR and may subsequently inhibit angiogenesis.",
year = "2008",
month = may,
day = "20",
doi = "10.1200/jco.2008.26.15\_suppl.19055",
language = "American English",
volume = "26",
pages = "19055--19055",
journal = "Journal of Clinical Oncology",
number = "15\_suppl",
}